Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.66 USD | +3.29% | -6.56% | +0.23% |
08/05 | Syndax Pharmaceuticals Q1 Net Loss Widens | MT |
08/05 | Transcript : Syndax Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.23% | 1.84B | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+49.39% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- SNDX Stock
- News Syndax Pharmaceuticals, Inc.
- JPMorgan Adjusts Price Target on Syndax Pharmaceuticals to $33 From $36, Keeps Overweight Rating